NOTCH3 and pulmonary arterial hypertension: Longitudinal studies examining the long-term effects of targeting NOTCH3 signaling on disease progression and patient outcomes will provide valuable insights into the therapeutic potential of modulating this pathway for the successful treatment of PAH.